Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
June-2017 Volume 13 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
June-2017 Volume 13 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

AURKA mRNA expression is an independent predictor of poor prognosis in patients with non-small cell lung cancer

  • Authors:
    • Ahmed S.K. Al‑Khafaji
    • Michael W. Marcus
    • Michael P.A. Davies
    • Janet M. Risk
    • Richard J. Shaw
    • John K. Field
    • Triantafillos Liloglou
  • View Affiliations / Copyright

    Affiliations: Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, Liverpool L7 8TX, UK
  • Pages: 4463-4468
    |
    Published online on: April 7, 2017
       https://doi.org/10.3892/ol.2017.6012
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Deregulation of mitotic spindle genes has been reported to contribute to the development and progression of malignant tumours. The aim of the present study was to explore the association between the expression profiles of Aurora kinases (AURKA, AURKB and AURKC), cytoskeleton‑associated protein 5 (CKAP5), discs large‑associated protein 5 (DLGAP5), kinesin‑like protein 11 (KIF11), microtubule nucleation factor (TPX2), monopolar spindle 1 kinase (TTK), and β‑tubulins (TUBB) and (TUBB3) genes and clinicopathological characteristics in human non‑small cell lung carcinoma (NSCLC). Reverse transcription-quantitative polymerase chain reaction‑based RNA gene expression profiles of 132 NSCLC and 44 adjacent wild‑type tissues were generated, and Cox's proportional hazard regression was used to examine associations. With the exception of AURKC, all genes exhibited increased expression in NSCLC tissues. Of the 10 genes examined, only AURKA was significantly associated with prognosis in NSCLC. Multivariate Cox's regression analysis demonstrated that AURKA mRNA expression [hazard ratio (HR), 1.81; 95% confidence interval (CI), 1.16‑2.84; P=0.009], age (HR, 1.03; 95% CI, 1.00‑1.06; P=0.020), pathological tumour stage 2 (HR, 2.43; 95% CI, 1.16‑5.10; P=0.019) and involvement of distal nodes (pathological node stage 2) (HR, 3.14; 95% CI, 1.24‑7.99; P=0.016) were independent predictors of poor prognosis in patients with NSCLC. Poor prognosis of patients with increased AURKA expression suggests that those patients may benefit from surrogate therapy with AURKA inhibitors.
View Figures

Figure 1

Figure 2

Figure 3

View References

1 

Field JK, Devaraj A, Duffy SW and Baldwin DR: CT screening for lung cancer: Is the evidence strong enough? Lung Cancer. 91:29–35. 2016. View Article : Google Scholar : PubMed/NCBI

2 

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015. View Article : Google Scholar : PubMed/NCBI

3 

Lacroix L, Commo F and Soria JC: Gene expression profiling of non-small-cell lung cancer. Expert Rev Mol Diagn. 8:167–178. 2008. View Article : Google Scholar : PubMed/NCBI

4 

Wassmann K and Benezra R: Mitotic checkpoints: From yeast to cancer. Curr Opin Genet Dev. 11:83–90. 2001. View Article : Google Scholar : PubMed/NCBI

5 

Fu J, Bian M, Jiang Q and Zhang C: Roles of aurora kinases in mitosis and tumorigenesis. Mol Cancer Res. 5:1–10. 2007. View Article : Google Scholar : PubMed/NCBI

6 

Martens-de Kemp SR, Nagel R, Stigter-van Walsum M, van der Meulen IH, van Beusechem VW, Braakhuis BJ and Brakenhoff RH: Functional genetic screens identify genes essential for tumor cell survival in head and neck and lung cancer. Clin Cancer Res. 19:1994–2003. 2013. View Article : Google Scholar : PubMed/NCBI

7 

Sankaran S and Parvin JD: Centrosome function in normal and tumor cells. J Cell Biochem. 99:1240–1250. 2006. View Article : Google Scholar : PubMed/NCBI

8 

Tanenbaum ME and Medema RH: Mechanisms of centrosome separation and bipolar spindle assembly. Dev Cell. 19:797–806. 2010. View Article : Google Scholar : PubMed/NCBI

9 

Royle SJ: The role of clathrin in mitotic spindle organisation. J Cell Sci. 125:19–28. 2012. View Article : Google Scholar : PubMed/NCBI

10 

Manning AL and Compton DA: Structural and regulatory roles of nonmotor spindle proteins. Curr Opin Cell Biol. 20:101–106. 2008. View Article : Google Scholar : PubMed/NCBI

11 

Leandro-Garcia LJ, Leskelä S, Landa I, Montero-Conde C, López-Jiménez E, Letón R, Cascón A, Robledo M and Rodríguez-Antona C: Tumoral and tissue-specific expression of the major human beta-tubulin isotypes. Cytoskeleton (Hoboken). 67:214–223. 2010. View Article : Google Scholar : PubMed/NCBI

12 

Jelluma N, Brenkman AB, van den Broek NJ, Cruijsen CW, van Osch MH, Lens SM, Medema RH and Kops GJ: Mps1 phosphorylates Borealin to control Aurora B activity and chromosome alignment. Cell. 132:233–246. 2008. View Article : Google Scholar : PubMed/NCBI

13 

Nguyen HG, Makitalo M, Yang D, Chinnappan D, St Hilaire C and Ravid K: Deregulated Aurora-B induced tetraploidy promotes tumorigenesis. FASEB J. 23:2741–2748. 2009. View Article : Google Scholar : PubMed/NCBI

14 

Slattery SD, Mancini MA, Brinkley BR and Hall RM: Aurora-C kinase supports mitotic progression in the absence of Aurora-B. Cell Cycle. 8:2984–2994. 2009. View Article : Google Scholar : PubMed/NCBI

15 

Kadara H, Behrens C, Yuan P, Solis L, Liu D, Gu X, Minna JD, Lee JJ, Kim E, Hong WK, et al: A five-gene and corresponding protein signature for stage-I lung adenocarcinoma prognosis. Clin Cancer Res. 17:1490–1501. 2011. View Article : Google Scholar : PubMed/NCBI

16 

Ogawa E, Takenaka K, Katakura H, Adachi M, Otake Y, Toda Y, Kotani H, Manabe T, Wada H and Tanaka F: Perimembrane Aurora-A expression is a significant prognostic factor in correlation with proliferative activity in non-small-cell lung cancer (NSCLC). Ann Surg Oncol. 15:547–554. 2008. View Article : Google Scholar : PubMed/NCBI

17 

Lo Iacono M, Monica V, Saviozzi S, Ceppi P, Bracco E, Papotti M and Scagliotti GV: Aurora kinase A expression is associated with lung cancer histological-subtypes and with tumor de-differentiation. J Transl Med. 9:1002011. View Article : Google Scholar : PubMed/NCBI

18 

Takeshita M, Koga T, Takayama K, Kouso H, Nishimura-Ikeda Y, Yoshino I, Maehara Y, Nakanishi Y and Sueishi K: CHFR expression is preferentially impaired in smoking-related squamous cell carcinoma of the lung, and the diminished expression significantly harms outcomes. Int J Cancer. 123:1623–1630. 2008. View Article : Google Scholar : PubMed/NCBI

19 

Vischioni B, Oudejans JJ, Vos W, Rodriguez JA and Giaccone G: Frequent overexpression of aurora B kinase, a novel drug target, in non-small cell lung carcinoma patients. Mol Cancer Ther. 5:2905–2913. 2006. View Article : Google Scholar : PubMed/NCBI

20 

Smith SL, Bowers NL, Betticher DC, Gautschi O, Ratschiller D, Hoban PR, Booton R, Santibáñez-Koref MF and Heighway J: Overexpression of aurora B kinase (AURKB) in primary non-small cell lung carcinoma is frequent, generally driven from one allele, and correlates with the level of genetic instability. Br J Cancer. 93:719–729. 2005. View Article : Google Scholar : PubMed/NCBI

21 

Perumal D, Singh S, Yoder SJ, Bloom GC and Chellappan SP: A novel five gene signature derived from stem-like side population cells predicts overall and recurrence-free survival in NSCLC. PLoS One. 7:e435892012. View Article : Google Scholar : PubMed/NCBI

22 

Cassidy A, Myles JP, van Tongeren M, Page RD, Liloglou T, Duffy SW and Field JK: The LLP risk model: An individual risk prediction model for lung cancer. Br J Cancer. 98:270–276. 2008. View Article : Google Scholar : PubMed/NCBI

23 

Sato M, Vaughan MB, Girard L, Peyton M, Lee W, Shames DS, Ramirez RD, Sunaga N, Gazdar AF, Shay JW and Minna JD: Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells. Cancer Res. 66:2116–2128. 2006. View Article : Google Scholar : PubMed/NCBI

24 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

25 

Bursac Z, Gauss CH, Williams DK and Hosmer DW: Purposeful selection of variables in logistic regression. Source Code Biol Med. 3:172008. View Article : Google Scholar : PubMed/NCBI

26 

Cimini D and Degrassi F: Aneuploidy: A matter of bad connections. Trends Cell Biol. 15:442–451. 2005. View Article : Google Scholar : PubMed/NCBI

27 

Vader G and Lens SM: The aurora kinase family in cell division and cancer. Biochim Biophys Acta. 1786:60–72. 2008.PubMed/NCBI

28 

Garrido G and Vernos I: Non-centrosomal TPX2-dependent regulation of the aurora a kinase: Functional implications for healthy and pathological cell division. Front Oncol. 6:882016. View Article : Google Scholar : PubMed/NCBI

29 

Eymin B and Gazzeri S: Role of cell cycle regulators in lung carcinogenesis. Cell Adh Migr. 4:114–123. 2010. View Article : Google Scholar : PubMed/NCBI

30 

Tang H, Xiao G, Behrens C, Schiller J, Allen J, Chow CW, Suraokar M, Corvalan A, Mao J, White MA, et al: A 12-gene set predicts survival benefits from adjuvant chemotherapy in non-small cell lung cancer patients. Clin Cancer Res. 19:1577–1586. 2013. View Article : Google Scholar : PubMed/NCBI

31 

Marumoto T, Zhang D and Saya H: Aurora-A-a guardian of poles. Nat Rev Cancer. 5:42–50. 2005. View Article : Google Scholar : PubMed/NCBI

32 

Katayama H, Sasai K, Kawai H, Yuan ZM, Bondaruk J, Suzuki F, Fujii S, Arlinghaus RB, Czerniak BA and Sen S: Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53. Nat Genet. 36:55–62. 2004. View Article : Google Scholar : PubMed/NCBI

33 

Jeng YM, Peng SY, Lin CY and Hsu HC: Overexpression and amplification of Aurora-A in hepatocellular carcinoma. Clin Cancer Res. 10:2065–2071. 2004. View Article : Google Scholar : PubMed/NCBI

34 

Lassmann S, Shen Y, Jütting U, Wiehle P, Walch A, Gitsch G, Hasenburg A and Werner M: Predictive value of Aurora-A/STK15 expression for late stage epithelial ovarian cancer patients treated by adjuvant chemotherapy. Clin Cancer Res. 13:4083–4091. 2007. View Article : Google Scholar : PubMed/NCBI

35 

Chen Z, Fillmore CM, Hammerman PS, Kim CF and Wong KK: Non-small-cell lung cancers: A heterogeneous set of diseases. Nat Rev Cancer. 14:535–546. 2014. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Al‑Khafaji AS, Marcus MW, Davies MP, Risk JM, Shaw RJ, Field JK and Liloglou T: AURKA mRNA expression is an independent predictor of poor prognosis in patients with non-small cell lung cancer. Oncol Lett 13: 4463-4468, 2017.
APA
Al‑Khafaji, A.S., Marcus, M.W., Davies, M.P., Risk, J.M., Shaw, R.J., Field, J.K., & Liloglou, T. (2017). AURKA mRNA expression is an independent predictor of poor prognosis in patients with non-small cell lung cancer. Oncology Letters, 13, 4463-4468. https://doi.org/10.3892/ol.2017.6012
MLA
Al‑Khafaji, A. S., Marcus, M. W., Davies, M. P., Risk, J. M., Shaw, R. J., Field, J. K., Liloglou, T."AURKA mRNA expression is an independent predictor of poor prognosis in patients with non-small cell lung cancer". Oncology Letters 13.6 (2017): 4463-4468.
Chicago
Al‑Khafaji, A. S., Marcus, M. W., Davies, M. P., Risk, J. M., Shaw, R. J., Field, J. K., Liloglou, T."AURKA mRNA expression is an independent predictor of poor prognosis in patients with non-small cell lung cancer". Oncology Letters 13, no. 6 (2017): 4463-4468. https://doi.org/10.3892/ol.2017.6012
Copy and paste a formatted citation
x
Spandidos Publications style
Al‑Khafaji AS, Marcus MW, Davies MP, Risk JM, Shaw RJ, Field JK and Liloglou T: AURKA mRNA expression is an independent predictor of poor prognosis in patients with non-small cell lung cancer. Oncol Lett 13: 4463-4468, 2017.
APA
Al‑Khafaji, A.S., Marcus, M.W., Davies, M.P., Risk, J.M., Shaw, R.J., Field, J.K., & Liloglou, T. (2017). AURKA mRNA expression is an independent predictor of poor prognosis in patients with non-small cell lung cancer. Oncology Letters, 13, 4463-4468. https://doi.org/10.3892/ol.2017.6012
MLA
Al‑Khafaji, A. S., Marcus, M. W., Davies, M. P., Risk, J. M., Shaw, R. J., Field, J. K., Liloglou, T."AURKA mRNA expression is an independent predictor of poor prognosis in patients with non-small cell lung cancer". Oncology Letters 13.6 (2017): 4463-4468.
Chicago
Al‑Khafaji, A. S., Marcus, M. W., Davies, M. P., Risk, J. M., Shaw, R. J., Field, J. K., Liloglou, T."AURKA mRNA expression is an independent predictor of poor prognosis in patients with non-small cell lung cancer". Oncology Letters 13, no. 6 (2017): 4463-4468. https://doi.org/10.3892/ol.2017.6012
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team